Skip to content

A phase III sTudy evaluating the efficacy and safety of Trans-Esophageal Motor-evoked PoTential monitoring and the special electrode during aortic surgery

A phase III sTudy evaluating the efficacy and safety of Trans-Esophageal Motor-evoked PoTential monitoring and the special electrode during aortic surgery - ATTEMPT

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2042230116
Enrollment
110
Registered
2023-12-15
Start date
2024-02-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients undergoing aortic surgery carrying the risk of ischemic spinal cord injury ischemic spinal cord injury, aortic aneurysm, aortic dissection

Interventions

The test product Transesophageal spinal cord stimulation electrode" is inserted into the esophagus to monitor TE-MEP, in addition to the TC-MEP as a usual care.
motor evoked potential

Sponsors

Norihiko Shiiya
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) patients scheduled to undergo aortic surgery carrying the risk of ischemic spinal cord injury and TC-MEP 2) patients aged 20 years or more on the day of giving informed consent 3) patients giving written informed consent to be enrolled in this trial

Exclusion criteria

Exclusion criteria: Patients meeting any of the following exclusion criteria on the day of enrollment are excluded. 1) patients undergoing aortic surgery within 24 hours after non-scheduled admission 2) patients having esophageal abnormality (severe compression or deviation causing esophageal obstruction by tumors or something else, esophageal varices with a arisk of bleeding, esophagus not locating in the normal anatomical position at theT4 level such as post-esophageal surgery, etc) 3) patients having head skin abnormality (resulting in difficulty of setting the transcranial stimuation elecrodes) at the stimulation points 4) patients having paralysis (such as hemiplegia or paraplegia) or neuromusclar diseases with severe 5) patients unable to walk without assistance due to prolonged bed rest or some other reasons 6) patients judged unsuitable by the investigators or subinvstigators

Design outcomes

Primary

MeasureTime frame
diagnostic specificity for the neurological evaluation on awakening (within 18 hours after the conclusion of surgery) by the change in the amplitude of motor evoked potenstials at the conclusion of surgery

Secondary

MeasureTime frame
diagnostic sensitivity for the neurological outcomes on the day 8 by the presence or absence of intraoperative change (including the transient one) in the amplitude of TC-MEP and TE-MEP agreement between the intraoperative changes in the ampitude of TC-MEP and TE-MEP baseline amplitude of TC-MEP and TE-MEP stability of monitoring (requirements and frequency of repositioning the stimulation electrodes) diagnostic sensitivity for the neurological evaluation on awakening (within 18 hours after the conclusion of surgery) by the change in the amplitude of motor evoked potenstials at the conclusion of surgery diagnostic specificity for the neurological outcomes on the day 8 by the change in the amplitude of motor evoked potenstials at the conclusion of surgery diagnostic sensitivity for the neurological outcomes on the day 8 by the change in the amplitude of motor evoked potenstials at the conclusion of surgery diagnostic specificity for the neurological outcomes on the day 8 by the presence or absence of intraoperative change (including the transient one) in the amplitude of TC-MEP and TE-MEP agreement between the neurological evaluation on awakening (within 18 hours after the conclusion of surgery) and the neurological outcomes on the day 8

Contacts

Public ContactShiiya Norihiko

Hakodate National Hospital

shiyanor@hama-med.ac.jp+81-138-51-6281

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026